About Xlear, Inc. Xlear, Inc. specializes in xylitol-based products for oral and nasal hygiene. The company is dedicated to improving health outcomes through innovative, natural solutions.

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Just a few puffs into each nostril, and you're protected against infection from nasty cold viruses - that is, according to claims made for many nasal sprays. Can they really do this?Well, not directly ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

For instance, he referenced a 2024 clinical trial demonstrating that nasal hygiene reduced severe ... among others. Xlear has supported extensive research on the advantages of xylitol over fluoride.

Whether you’re fighting off a winter cold or seasonal allergies, experts share how to find some relief. View Entire Post › ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

He said many ear nose and throat specialists can clear harmful toxins from inflamed sinuses with a procedure called endoscopic cyclone irrigation. "You basically rinse it out with antibiotics or ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

Nathan Jones, CEO of Xlear, Inc. (pronounced "Clear"), officially submitted testimony to the Senate Committee on Health, Education, Labor and Pensions in support of Robert F. Kennedy Jr.'s ...